| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |